Improvement Beyond Dose Standards

This brief provides details regarding effective dose monitoring and reporting to ensure compliance with the Joint Commission’s Radiation Dose Standards.

Analytics and Interventions to Optimize Imaging Quality and Patient Safety

Resource thumbnail imageComputed tomography (CT) and magnetic resonance imaging volume has more than tripled in the past 30 years, enabling faster and more accurate diagnoses, reduced need for surgeries, fewer hospital admissions and faster patient throughput. Along with these advances has come scrutiny from regulators, the media and the public. Even with a small perceived risk to most individuals, the magnitude of CT utilization raises concerns.

One byproduct of this focus has been a call for accountability for both the frequency of medical imaging examinations involving ionizing radiation and the magnitude of the dose exposure. As a result, programmatic radiation dose monitoring has emerged as a valuable tool to understand, manage and mitigate dose concerns.

Some fast facts on CT:

  • CT is responsible for 25% of the U.S. per capita radiation from all sources, including background radiation.
  • The threshold for and potential magnitude of risks for cancer from low-level radiation are the subject of much dispute in the scientific community.
  • Studies have found as many as 4% of patients may be receiving too large a radiation dose from CT.
  • Up to about 10% of all CT examinations are performed in children; the National Institutes of Health has found a correlation between CT scans in children and their subsequent risk of developing cancers.

Would your organization pass an audit today regarding The Joint Commission’s Radiation Dose Standards? Imalogix helps organizations easily meet The Joint Commission’s diagnostic imaging requirements, which took effect in 2015, and provides the infrastructure of advanced analytics to help systematically reduce dose exposure to improve patient safety.

Download the issue brief to learn more.